Eosinophilic cholangitis treatment with budesonide

doi:10.4254/wjh.v9.i36.1385

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5822)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

341

WORD

211

HTML

2430

Figures (1-2)

238

Sum=3220

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1045

Download

1557

Sum=2602

Dec 28, 2017 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Dec 28, 2017; 9(36): 1385-1388
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1385

Full Size Figure Download Figure

Figure 2 Histology from liver biopsy at 20 × magnification with HE staining: Portal and bile duct inflammation with up to 18 Eos/HPF. There is bile ductular proliferation and portal tract oedema.

Citation: De Roza MA, Lim CH. Eosinophilic cholangitis treatment with budesonide. World J Hepatol 2017; 9(36): 1385-1388
URL: https://www.wjgnet.com/1948-5182/full/v9/i36/1385.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i36.1385